The First Affiliated Hospital of Xiamen University
2 clinical trials · 2 recruiting · OTHER
Trials by The First Affiliated Hospital of Xiamen University
RECRUITINGPhase 2NCT06158399
AZA Combined With RCHOP in P53-mutated DLBCL.
To evaluate the efficacy and adverse effects of Azacitidine in combination with R-CHOP (ARCHOP) for the treatment of TP53-mutated previously untreated Diffuse large B-cell lymphoma
Sponsor: The First Affiliated Hospital of Xiamen UniversityEnrolling: 521 location
DLBCL - Diffuse Large B Cell LymphomaTP53
RECRUITINGNCT03799653
A Nurse Cohort Study in Xiamen, China
The Nurse Cohort Study Xiamen (NCSX) is an open-ended prospective cohort study with very broad research aims. The primary objectives of the NCSX is planned to examine genetic,...
Sponsor: The First Affiliated Hospital of Xiamen UniversityEnrolling: 100001 location
Hypertension